Targeted Intracellular Drug Delivery by Receptor Mediated Endocytosis
These facets are elucidated with the help of specific examples from academic research and also clinical trials, wherever relevant. In vitro cellular models relied on for assessing receptor mediated cellular targeting and in vivo models depicting clinical efficacy are focused on in a separate section...
| Other Authors: | , , |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
Cham
Springer International Publishing
2019, 2019
|
| Edition: | 1st ed. 2019 |
| Series: | AAPS Advances in the Pharmaceutical Sciences Series
|
| Subjects: | |
| Online Access: | |
| Collection: | Springer eBooks 2005- - Collection details see MPG.ReNa |
Table of Contents:
- Part 1-Introduction and overview
- Intracellular Delivery in Cancer and Infectious Diseases
- Intracellular Delivery by Receptor Mediated Endocytosis
- Part 2-Receptor and Receptor Medicated Endocytosis in Cancer
- Receptors Relevant for Cancer Therapeutics
- (chapters 3-8)
- Part 3-Receptors and Receptor Medicated Endocytosis in Infectious Diseases
- Receptors Relevant for Infectious Disease Therapeutics
- (chapters 9-13)
- Part 4-Common Receptors for Receptors and Receptor Mediated Endocytosis in Cancer and Infectious Diseases
- Chapters 14-17)
- Receptors Relevant for Cancer and Infectious Disease Therapeutics
- Part 5-Models for Evaluation of Targeted Delivery in Cancer and infectious Diseases
- In vitro and in vivo Models for Cancer and Infectious Diseases
- In vitro and in vivo Models for Infectious Diseases
- Part 6- Regulatory and Toxicity Issues
- Regulatory and Toxicity Issues in TargetedDelivery